CD274 and head and neck squamous cell carcinoma: In the present study, evaluation of immunohistochemical expression of PD-L1 on tumor cells and tumor-infiltrating immune cells in HNSCC revealed a high prevalence of PD-L1 expression (92%), using CPS, proving that PD-L1 IHC done given patient selection for immunotherapy is a promising technique.